2021-2027 Global and Regional Cyclophosphamide Industry Status and Prospects Professional Market Research Report Standard Version
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Cyclophosphamide market was valued at 649.11 Million USD in 2020 and will grow with a CAGR of 2.04% from 2020 to 2027, based on newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.Top 8 manufacturers took 75.4% market share in 2019.
By Market Verdors:
Baxter
Novartis
Hikma Pharmaceuticals
Amneal Pharmaceuticals LLC
Jiangsu Hengrui Medicine
NorthStar Rx LLC
GLS Pharma
CSC Pharmaceuticals International
By Types:
High-Dose
Low-Dose
By Applications:
Cancer
Autoimmune Diseases
AL Amyloidosis
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Cyclophosphamide Market Size Analysis from 2022 to 2027
1.5.1 Global Cyclophosphamide Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Cyclophosphamide Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Cyclophosphamide Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Cyclophosphamide Industry Impact
Chapter 2 Global Cyclophosphamide Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cyclophosphamide (Volume and Value) by Type
2.1.1 Global Cyclophosphamide Consumption and Market Share by Type (2016-2021)
2.1.2 Global Cyclophosphamide Revenue and Market Share by Type (2016-2021)
2.2 Global Cyclophosphamide (Volume and Value) by Application
2.2.1 Global Cyclophosphamide Consumption and Market Share by Application (2016-2021)
2.2.2 Global Cyclophosphamide Revenue and Market Share by Application (2016-2021)
2.3 Global Cyclophosphamide (Volume and Value) by Regions
2.3.1 Global Cyclophosphamide Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Cyclophosphamide Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Cyclophosphamide Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Cyclophosphamide Consumption by Regions (2016-2021)
4.2 North America Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
4.10 South America Cyclophosphamide Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Cyclophosphamide Market Analysis
5.1 North America Cyclophosphamide Consumption and Value Analysis
5.1.1 North America Cyclophosphamide Market Under COVID-19
5.2 North America Cyclophosphamide Consumption Volume by Types
5.3 North America Cyclophosphamide Consumption Structure by Application
5.4 North America Cyclophosphamide Consumption by Top Countries
5.4.1 United States Cyclophosphamide Consumption Volume from 2016 to 2021
5.4.2 Canada Cyclophosphamide Consumption Volume from 2016 to 2021
5.4.3 Mexico Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 6 East Asia Cyclophosphamide Market Analysis
6.1 East Asia Cyclophosphamide Consumption and Value Analysis
6.1.1 East Asia Cyclophosphamide Market Under COVID-19
6.2 East Asia Cyclophosphamide Consumption Volume by Types
6.3 East Asia Cyclophosphamide Consumption Structure by Application
6.4 East Asia Cyclophosphamide Consumption by Top Countries
6.4.1 China Cyclophosphamide Consumption Volume from 2016 to 2021
6.4.2 Japan Cyclophosphamide Consumption Volume from 2016 to 2021
6.4.3 South Korea Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 7 Europe Cyclophosphamide Market Analysis
7.1 Europe Cyclophosphamide Consumption and Value Analysis
7.1.1 Europe Cyclophosphamide Market Under COVID-19
7.2 Europe Cyclophosphamide Consumption Volume by Types
7.3 Europe Cyclophosphamide Consumption Structure by Application
7.4 Europe Cyclophosphamide Consumption by Top Countries
7.4.1 Germany Cyclophosphamide Consumption Volume from 2016 to 2021
7.4.2 UK Cyclophosphamide Consumption Volume from 2016 to 2021
7.4.3 France Cyclophosphamide Consumption Volume from 2016 to 2021
7.4.4 Italy Cyclophosphamide Consumption Volume from 2016 to 2021
7.4.5 Russia Cyclophosphamide Consumption Volume from 2016 to 2021
7.4.6 Spain Cyclophosphamide Consumption Volume from 2016 to 2021
7.4.7 Netherlands Cyclophosphamide Consumption Volume from 2016 to 2021
7.4.8 Switzerland Cyclophosphamide Consumption Volume from 2016 to 2021
7.4.9 Poland Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 8 South Asia Cyclophosphamide Market Analysis
8.1 South Asia Cyclophosphamide Consumption and Value Analysis
8.1.1 South Asia Cyclophosphamide Market Under COVID-19
8.2 South Asia Cyclophosphamide Consumption Volume by Types
8.3 South Asia Cyclophosphamide Consumption Structure by Application
8.4 South Asia Cyclophosphamide Consumption by Top Countries
8.4.1 India Cyclophosphamide Consumption Volume from 2016 to 2021
8.4.2 Pakistan Cyclophosphamide Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Cyclophosphamide Market Analysis
9.1 Southeast Asia Cyclophosphamide Consumption and Value Analysis
9.1.1 Southeast Asia Cyclophosphamide Market Under COVID-19
9.2 Southeast Asia Cyclophosphamide Consumption Volume by Types
9.3 Southeast Asia Cyclophosphamide Consumption Structure by Application
9.4 Southeast Asia Cyclophosphamide Consumption by Top Countries
9.4.1 Indonesia Cyclophosphamide Consumption Volume from 2016 to 2021
9.4.2 Thailand Cyclophosphamide Consumption Volume from 2016 to 2021
9.4.3 Singapore Cyclophosphamide Consumption Volume from 2016 to 2021
9.4.4 Malaysia Cyclophosphamide Consumption Volume from 2016 to 2021
9.4.5 Philippines Cyclophosphamide Consumption Volume from 2016 to 2021
9.4.6 Vietnam Cyclophosphamide Consumption Volume from 2016 to 2021
9.4.7 Myanmar Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 10 Middle East Cyclophosphamide Market Analysis
10.1 Middle East Cyclophosphamide Consumption and Value Analysis
10.1.1 Middle East Cyclophosphamide Market Under COVID-19
10.2 Middle East Cyclophosphamide Consumption Volume by Types
10.3 Middle East Cyclophosphamide Consumption Structure by Application
10.4 Middle East Cyclophosphamide Consumption by Top Countries
10.4.1 Turkey Cyclophosphamide Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Cyclophosphamide Consumption Volume from 2016 to 2021
10.4.3 Iran Cyclophosphamide Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Cyclophosphamide Consumption Volume from 2016 to 2021
10.4.5 Israel Cyclophosphamide Consumption Volume from 2016 to 2021
10.4.6 Iraq Cyclophosphamide Consumption Volume from 2016 to 2021
10.4.7 Qatar Cyclophosphamide Consumption Volume from 2016 to 2021
10.4.8 Kuwait Cyclophosphamide Consumption Volume from 2016 to 2021
10.4.9 Oman Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 11 Africa Cyclophosphamide Market Analysis
11.1 Africa Cyclophosphamide Consumption and Value Analysis
11.1.1 Africa Cyclophosphamide Market Under COVID-19
11.2 Africa Cyclophosphamide Consumption Volume by Types
11.3 Africa Cyclophosphamide Consumption Structure by Application
11.4 Africa Cyclophosphamide Consumption by Top Countries
11.4.1 Nigeria Cyclophosphamide Consumption Volume from 2016 to 2021
11.4.2 South Africa Cyclophosphamide Consumption Volume from 2016 to 2021
11.4.3 Egypt Cyclophosphamide Consumption Volume from 2016 to 2021
11.4.4 Algeria Cyclophosphamide Consumption Volume from 2016 to 2021
11.4.5 Morocco Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 12 Oceania Cyclophosphamide Market Analysis
12.1 Oceania Cyclophosphamide Consumption and Value Analysis
12.2 Oceania Cyclophosphamide Consumption Volume by Types
12.3 Oceania Cyclophosphamide Consumption Structure by Application
12.4 Oceania Cyclophosphamide Consumption by Top Countries
12.4.1 Australia Cyclophosphamide Consumption Volume from 2016 to 2021
12.4.2 New Zealand Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 13 South America Cyclophosphamide Market Analysis
13.1 South America Cyclophosphamide Consumption and Value Analysis
13.1.1 South America Cyclophosphamide Market Under COVID-19
13.2 South America Cyclophosphamide Consumption Volume by Types
13.3 South America Cyclophosphamide Consumption Structure by Application
13.4 South America Cyclophosphamide Consumption Volume by Major Countries
13.4.1 Brazil Cyclophosphamide Consumption Volume from 2016 to 2021
13.4.2 Argentina Cyclophosphamide Consumption Volume from 2016 to 2021
13.4.3 Columbia Cyclophosphamide Consumption Volume from 2016 to 2021
13.4.4 Chile Cyclophosphamide Consumption Volume from 2016 to 2021
13.4.5 Venezuela Cyclophosphamide Consumption Volume from 2016 to 2021
13.4.6 Peru Cyclophosphamide Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Cyclophosphamide Consumption Volume from 2016 to 2021
13.4.8 Ecuador Cyclophosphamide Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Cyclophosphamide Business
14.1 Baxter
14.1.1 Baxter Company Profile
14.1.2 Baxter Cyclophosphamide Product Specification
14.1.3 Baxter Cyclophosphamide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Novartis
14.2.1 Novartis Company Profile
14.2.2 Novartis Cyclophosphamide Product Specification
14.2.3 Novartis Cyclophosphamide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Hikma Pharmaceuticals
14.3.1 Hikma Pharmaceuticals Company Profile
14.3.2 Hikma Pharmaceuticals Cyclophosphamide Product Specification
14.3.3 Hikma Pharmaceuticals Cyclophosphamide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Amneal Pharmaceuticals LLC
14.4.1 Amneal Pharmaceuticals LLC Company Profile
14.4.2 Amneal Pharmaceuticals LLC Cyclophosphamide Product Specification
14.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Jiangsu Hengrui Medicine
14.5.1 Jiangsu Hengrui Medicine Company Profile
14.5.2 Jiangsu Hengrui Medicine Cyclophosphamide Product Specification
14.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 NorthStar Rx LLC
14.6.1 NorthStar Rx LLC Company Profile
14.6.2 NorthStar Rx LLC Cyclophosphamide Product Specification
14.6.3 NorthStar Rx LLC Cyclophosphamide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 GLS Pharma
14.7.1 GLS Pharma Company Profile
14.7.2 GLS Pharma Cyclophosphamide Product Specification
14.7.3 GLS Pharma Cyclophosphamide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 CSC Pharmaceuticals International
14.8.1 CSC Pharmaceuticals International Company Profile
14.8.2 CSC Pharmaceuticals International Cyclophosphamide Product Specification
14.8.3 CSC Pharmaceuticals International Cyclophosphamide Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Cyclophosphamide Market Forecast (2022-2027)
15.1 Global Cyclophosphamide Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Cyclophosphamide Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Cyclophosphamide Value and Growth Rate Forecast (2022-2027)
15.2 Global Cyclophosphamide Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Cyclophosphamide Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Cyclophosphamide Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Cyclophosphamide Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Cyclophosphamide Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Cyclophosphamide Consumption Forecast by Type (2022-2027)
15.3.2 Global Cyclophosphamide Revenue Forecast by Type (2022-2027)
15.3.3 Global Cyclophosphamide Price Forecast by Type (2022-2027)
15.4 Global Cyclophosphamide Consumption Volume Forecast by Application (2022-2027)
15.5 Cyclophosphamide Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Research Methodology:
Cyclophosphamide Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|